We are live on ! Find out more
PETX

Aratana Therapeutics, Inc.
PETX

Delisted

PETX was delisted on the 17th of July, 2019.

Back to rankings

82 hedge funds and large institutions have $276M invested in Aratana Therapeutics, Inc. in 2014 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 44 increasing their positions, 11 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 11

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

8% less funds holding

Funds holding: 89 → 82 (-7)

24% less capital invested

Capital invested by funds: $364M → $276M (-$88.3M)

39% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 18

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $5K

Holders
82
Holders Change
-7
Holders Change %
-7.87%
% of All Funds
2.38%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
11
Increased
44
Reduced
11
Closed
18
Calls
–
Puts
$5K
Net Calls
-$5K
Net Calls Change
+$43K

Top Buyers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
+$19.5M
2
Franklin Resources
Franklin Resources
California
+$8.77M
3
HCMT
Highland Capital Management (Texas)
Texas
+$7.99M
4
Jennison Associates
Jennison Associates
New York
+$7.74M
5
BC
Broadfin Capital
New York
+$7.58M

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$12.3M
2
RIM
RS Investment Management
California
-$8.88M
3
CIP
Chartwell Investment Partners
Pennsylvania
-$6.74M
4
FAM
Fred Alger Management
New York
-$3.53M
5
AP
Alydar Partners
Massachusetts
-$2.81M
Name Holding Trade Value Shares
Change 		Change in
Stake
Barclays
26
Barclays
United Kingdom
$2.1M +$2.54M +209,765 +40,185%
Millennium Management
27
Millennium Management
New York
$1.9M +$1.1M +90,832 +92%
HHC
28
Hutchin Hill Capital
New York
$1.88M +$163K +13,412 +8%
William Blair & Company
29
William Blair & Company
Illinois
$1.56M +$560K +46,180 +42%
VAM
30
Visium Asset Management
New York
$1.56M – – –
IHM
31
Iguana Healthcare Management
New York
$1.51M +$1.82M +150,000 New
Bank of New York Mellon
32
Bank of New York Mellon
New York
$1.33M -$34K -2,806 -2%
Geode Capital Management
33
Geode Capital Management
Massachusetts
$1.23M +$194K +15,961 +15%
TCIM
34
TIAA CREF Investment Management
New York
$1.14M +$179K +14,783 +15%
Alyeska Investment Group
35
Alyeska Investment Group
Illinois
$1.06M +$891K +73,483 +230%
DCM
36
Driehaus Capital Management
Illinois
$922K -$585K -48,276 -34%
BIM
37
BlackRock Investment Management
Delaware
$822K +$147K +12,117 +17%
FLAM
38
First Light Asset Management
Minnesota
$539K +$17.4K +1,433 +3%
California State Teachers Retirement System (CalSTRS)
39
California State Teachers Retirement System (CalSTRS)
California
$533K +$103K +8,456 +19%
SCM
40
Sterling Capital Management
North Carolina
$523K +$632K +52,110 New
Deutsche Bank
41
Deutsche Bank
Germany
$492K +$296K +24,408 +99%
Charles Schwab
42
Charles Schwab
California
$461K – – –
TA
43
Teachers Advisors
New York
$460K +$135K +11,121 +32%
EWM
44
Evercore Wealth Management
New York
$432K +$465K +38,386 +816%
KCM
45
Kornitzer Capital Management
Kansas
$416K +$502K +41,400 New
PP
46
PDT Partners
New York
$410K +$495K +40,867 New
Swiss National Bank
47
Swiss National Bank
Switzerland
$365K +$255K +21,000 +136%
Mariner
48
Mariner
Kansas
$315K +$24.5K +2,020 +7%
WMSA
49
Weiss Multi-Strategy Advisers
New York
$301K +$60.6K +5,000 +20%
Bank of Montreal
50
Bank of Montreal
Ontario, Canada
$291K -$2.42K -200 -0.7%
1
2
3 4

PETX Hedge Fund Activity: Q3 2014 in Review

82 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Aratana Therapeutics, Inc. (PETX) for Q3 2014, worth a combined $276M — down 24% from $364M a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of PETX and 11 opened new positions — a net loss of 7 holders — while 11 trimmed existing stakes and 44 added.

The largest buyer was Wellington Management Group, adding an estimated $19.5M. The largest seller was Deerfield Management, exiting entirely with an estimated $12.3M sold.

  • 82 institutional investors held Aratana Therapeutics, Inc. (PETX) as of Q3 2014, down from 89 in Q2 2014.
  • Funds reported $276M of Aratana Therapeutics, Inc. stock for Q3 2014, down 24% quarter-over-quarter.
  • 11 funds opened new Aratana Therapeutics, Inc. positions in Q3 2014 and 18 closed out, a net change of -7 holders.
  • The largest Aratana Therapeutics, Inc. buyer in Q3 2014 was Wellington Management Group, an estimated $19.5M added.
  • The largest Aratana Therapeutics, Inc. seller in Q3 2014 was Deerfield Management, an estimated $12.3M sold.

Based on aggregated 13F filings for Q3 2014.